Diabetic retinopathy

Clinical Cornerstone

Volumn 5, Issue 2, 2003, Pages 12-21

  Lightman, Susan ^a   Towler, Hamish M A ^b  

^a UNIVERSITY COLLEGE LONDON   (United Kingdom)

^b WHIPPS CROSS UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

GLUCOSE; LIPID;

ARTICLE; BLINDNESS; BLOOD PRESSURE REGULATION; DEVELOPED COUNTRY; DIABETES CONTROL; DIABETES MELLITUS; DIABETIC RETINOPATHY; GLUCOSE BLOOD LEVEL; HUMAN; HYPERTENSION; LASER COAGULATION; LIPID BLOOD LEVEL; NON INSULIN DEPENDENT DIABETES MELLITUS; OPHTHALMOSCOPY; PROGNOSIS; PROLIFERATIVE RETINOPATHY; RETINA MACULA EDEMA; SCREENING TEST; VISUAL IMPAIRMENT;

EID: 0037640956     PISSN: 10983597     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1098-3597(03)90015-9     Document Type: Article

References (30)

1. Tielsch JM, Sommer A, Witt K, et al. Blindness and visual impairment in an American urban population. The Baltimore Eye Survey. Arch Ophthalmol. 1990;108:286-290.
2. VanNewkirk MR, Weih L, McCarty CA, Taylor HR. Cause-specific prevalence of bilateral visual impairment in Victoria, Australia: The Visual Impairment Project. Ophthalmology. 2001;108: 960-967.
3. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiologic Study: II. Prevalence and risk of diabetic retinopathy when age at diagnosis is less than 30 years. Arch Ophthalmol. 1984;102: 520-526.
4. The Diabetes Control and Complications Trial Research Group. The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus. N Engl J Med. 1993;329:977-986.
5. Klein R, Klein BEK, Moss SE, et al. The Wisconsin Epidemiologic Study: III. Prevalence and risk of diabetic retinopathy when age at diagnosis is greater than 30 years. Arch Ophthalmol. 1984;102: 527-533.
6. The Diabetic Retinopathy Study Research Group. Photocoagulation treatment of proliferative diabetic retinopathy. Clinical application of Diabetic Retinopathy Study (DRS) findings, DRS Report Number 8. Ophthalmology. 1981;88:583-600.
7. Early Treatment Diabetic Retinopathy Study Research Group. Photocoagulation for diabetic macular edema. Arch Ophthalmol. 1985;103: 1796-1806.
8. Javitt JC, Aiello LP. Cost-effectiveness of detecting and treating diabetic retinopathy. Ann Intern Med. 1996;124:164-169.
9. Dasbach EJ, Fryback DG, Newcomb PA, et al. Cost effectiveness of strategies for detecting diabetic retinopathy. Med Care. 1991;29:20-39.
10. Younis N, Broadbent DM, Vora JP, Harding SP. Incidence of sight-threatening retinopathy in patients with type 2 diabetes in the Liverpool Diabetic Eye Study: A cohort study. Lancet. 2003;36: 195-200.
11. National Institute for Clinical Excellence. Inherited clinical guideline E. Management of type 2 diabetes: Retinopathy-screening and early management. London: National Institute for Clinical Excellence; 2002.
12. Harding SP, Broadbent DM, Neoh C, et al. Sensitivity and specificity of photography and direct ophthalmoscopy in screening for sight-threatening eye disease-The Liverpool Diabetic Eye Study. BMJ. 1995;311:1131-1135.
13. Gibbons RL, Owens DR, Allen JC, et al. Practical application of the European Field Guide in screening for diabetic retinopathy by using ophthalmoscopy and 35mm retinal slides. Acta Diabetol. 1998;41:59-64.
14. Rudnisky CJ, Hinz BJ, Tennant MT, et al. High resolution stereoscopic digital fundus photography versus contact lens biomicroscopy for the detection of clinically significant macular edema. Ophthalmology. 2002;109:267-274.
15. Fransen SR, Leonard-Martin TC, Feuer WJ, Hildebrand PL. Clinical evaluation of patients with diabetic retinopathy: Accuracy of the Inoveon diabetic retinopathy-3DT system. Ophthalmology. 2002;109:595-601.
16. Mason J, Drummond M. Screening for diabetic retinopathy by optometrists: Effectiveness and cost effectiveness. NHS Centre for Reviews and Dissemination, University of York; 1995.
17. Kleinstein RN, Roseman JM, Herman WH, et al. Detection of diabetic retinopathy by optometrists. J Am Optom Assoc. 1987;58:879-882.
18. Prasda S, Kamath GG, Jones K, et al. Effectiveness of optometrist screening for diabetic retinopathy using slit lamp biomicroscopy. Eye. 2001;15: 595-601.
19. Leslie RD, Pozzilli P. An introduction to new advances in diabetes. Diabetes Metab Res Rev. 2002;18(Suppl 1):S1-S6.
20. UK Prospective Diabetes Study Group. Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38. BMJ. 1998;317:703-713.
21. Bandello F, Lanzetta P, Menchini U. When and how to do a grid laser for diabetic macular edema. Doc Ophthalmol. 1999;97:415-419.
22. Chee CK, Flanagan DW. Visual field loss with capillary non-perfusion in preproliferative and early proliferative diabetic retinopathy. Br J Ophthalmol. 1993;77:726-730.
23. Temple RC, Aldridge VA, Sampson MJ, et al. Impact of pregnancy on the progression of diabetic retinopathy in type 1 diabetes. Diabet Med. 2001; 18:573-577.
24. Jonas JB, Kreissig I, Sofker A, Degenring RF. Intravitreal injection of triamcinolone for diffuse diabetic macular edema. Arch Ophthalmol. 2003;121:57-61.
25. Capone A Jr, Panozzo G. Vitrectomy for refractory diabetic macular edema. Semin Ophthalmol. 2000; 15:78-80.
26. Ozaki H, Seo MS, Ozaki K, et al. Blockade of vascular endothelial cell growth factor receptor signaling is sufficient to completely prevent retinal neovascularization. Am J Pathol. 2000;156:697-707.
27. Aiello LP, Bursell SE, Clermont A, et al. Vascular endothelial growth factor-induced retinal permeability is mediated by protein kinase C in vivo and suppressed by an orally effective beta-isoform-selective inhibitor. Diabetes. 1997;46:1473-1480.
28. Chew EY, Benson WE, Remaley NA, et al. Results after lens extraction in patients with diabetic retinopathy: Early treatment diabetic retinopathy study report number 25. Arch Ophthalmol. 1999;117: 1600-1606.
29. Regillo CD, Brown GC, Savino PJ, et al. Diabetic papillopathy. Patient characteristics and fundus findings. Arch Ophthalmol. 1995;113:889-895.
30. Jacobson DM. Pupil involvement in patients with diabetes-associated oculomotor nerve palsy. Arch Ophthalmol. 1998;116:723-727.